RCEL insider transaction filings
AVITA Medical, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-24. Screen RCEL transaction legs live →
Insider transaction summary — last 90 days
2026-06-25 to 2026-09-23, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 2,000 shares, $7,940 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 2,000 shares @ $3.97 ($7,940) by O'Toole David D, filed 2026-08-24.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| O'Toole David D — CFO | 1 | 1 leg · 2,000 sh · $7,940 | — | — |
Recent Form 4 filings — AVITA Medical, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4/A | O'Toole David D — CFO | Purchase (P): 2,000 @ $3.97 | EDGAR |
| 2026-06-12 | 4 | O'Toole David D — CFO | Grant/award (A): 2,000 @ $3.97 | EDGAR |
| 2026-06-10 | 4 | Woody Joseph Fralin — Director | Purchase (P): 5,200 @ $4 | EDGAR |
| 2026-06-09 | 4 | Woody Joseph Fralin — Director | Purchase (P): 5,000 @ $4.20 · Purchase (P): 5,000 @ $4.18 | EDGAR |
| 2026-06-05 | 4 | Woody Joseph Fralin — Director | Purchase (P): 5,000 @ $4.10 · Purchase (P): 5,000 @ $4.09 | EDGAR |
| 2026-06-04 | 4 | Crowe Suzanne — Director | Grant/award (A): 22,214 · Grant/award (A): 16,133 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Woody Joseph Fralin — Director | Grant/award (A): 40,547 · Grant/award (A): 22,214 · Grant/award (A): 29,446 (derivative) @ $0 · Grant/award (A): 16,133 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Tarnoff Michael E — Director | Grant/award (A): 26,250 · Grant/award (A): 22,214 · Grant/award (A): 19,063 (derivative) @ $0 · Grant/award (A): 16,133 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | McNamara Robert — Director | Grant/award (A): 22,214 · Grant/award (A): 16,133 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | COOK JEREMY CURNOCK — Director | Grant/award (A): 22,214 · Grant/award (A): 16,133 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | REED JAN STERN — Director | Grant/award (A): 22,214 · Grant/award (A): 16,133 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Woody Joseph Fralin — Director | Purchase (P): 5,000 @ $4.34 · Purchase (P): 5,000 @ $4.26 · Purchase (P): 5,000 @ $4.18 · Purchase (P): 5,000 @ $4.21 | EDGAR |
| 2026-06-01 | 4 | Vance Cary Guy — President and CEO, Director | Grant/award (A): 5,000 @ $3.05 | EDGAR |
| 2026-06-01 | 4 | O'Toole David D — CFO | Grant/award (A): 5,000 @ $3.05 | EDGAR |
| 2026-05-20 | 4 | O'Toole David D — CFO | Purchase (P): 2,000 @ $4.26 | EDGAR |
| 2026-05-19 | 4 | O'Toole David D — CFO | Purchase (P): 2,000 @ $4.24 | EDGAR |
| 2026-03-11 | 4 | O'Toole David D — CFO | Purchase (P): 1,800 @ $4.78 | EDGAR |
| 2026-02-23 | 4 | O'Toole David D — CFO | Purchase (P): 3,000 @ $4.15 | EDGAR |
| 2026-02-19 | 4 | KELSEY NICOLE — Chief Legal Officer | Grant/award (A): 98,390 · Grant/award (A): 145,060 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | O'Toole David D — CFO | Grant/award (A): 105,470 · Grant/award (A): 155,510 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | McNamara Robert — Director | Purchase (P): 10,000 @ $4.50 | EDGAR |
| 2025-08-26 | 4 | O'Toole David D — CFO | Purchase (P): 2,000 @ $4.52 | EDGAR |
| 2025-08-20 | 4 | McNamara Robert — Director | Purchase (P): 10,000 @ $5 | EDGAR |
| 2025-08-12 | 4 | O'Toole David D — CFO | Purchase (P): 2,000 @ $4.81 | EDGAR |
| 2025-06-05 | 4 | Crowe Suzanne — Director | Grant/award (A): 10,022 · Grant/award (A): 4,295 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Panaccio Lou — Director | Grant/award (A): 10,022 · Grant/award (A): 4,295 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Vance Cary Guy — Director | Grant/award (A): 10,022 · Grant/award (A): 4,295 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | McNamara Robert — Director | Grant/award (A): 10,022 · Grant/award (A): 4,295 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | CORBETT JAMES — CEO, Director | Grant/award (A): 520,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | COOK JEREMY CURNOCK — Director | Grant/award (A): 10,022 · Grant/award (A): 4,295 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | REED JAN STERN — Director | Grant/award (A): 10,022 · Grant/award (A): 4,295 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | O'Toole David D — CFO | Grant/award (A): 1,923 @ $4.78 | EDGAR |
| 2025-03-10 | 4 | McNamara Robert — Director | Purchase (P): 11,000 @ $8.30 | EDGAR |
| 2025-02-20 | 4 | O'Toole David D — CFO | Purchase (P): 1,000 @ $9.90 | EDGAR |
| 2025-02-20 | 4 | McNamara Robert — Director | Purchase (P): 10,000 @ $10.09 | EDGAR |
| 2025-02-19 | 4 | O'Toole David D — CFO | Purchase (P): 1,000 @ $10.25 | EDGAR |
| 2025-01-29 | 4 | Crowe Suzanne — Director | Purchase (P): 486 @ $13.15 | EDGAR |
| 2025-01-22 | 4 | KELSEY NICOLE — Chief Legal Officer | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | O'Toole David D — CFO | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | O'Toole David D — CFO | Grant/award (A): 785 @ $7.83 · Purchase (P): 475 @ $12.53 · Purchase (P): 500 @ $12.40 | EDGAR |
| 2024-08-20 | 4 | McNamara Robert — Director | Grant/award (A): 10,000 @ $9 | EDGAR |
| 2024-06-06 | 4 | Panaccio Lou — Director | Grant/award (A): 9,200 · Grant/award (A): 3,943 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Crowe Suzanne — Director | Grant/award (A): 9,200 · Grant/award (A): 3,943 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Vance Cary Guy — Director | Grant/award (A): 9,200 · Grant/award (A): 3,943 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | McNamara Robert — Director | Grant/award (A): 9,200 · Grant/award (A): 3,943 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CORBETT JAMES — CEO, Director | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | COOK JEREMY CURNOCK — Director | Grant/award (A): 9,200 · Grant/award (A): 3,943 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | REED JAN STERN — Director | Grant/award (A): 9,200 · Grant/award (A): 3,943 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Shiroma Donna — General Counsel | Grant/award (A): 2,225 @ $8.17 | EDGAR |
| 2024-06-03 | 4 | O'Toole David D — CFO | Purchase (P): 500 @ $9.20 · Purchase (P): 500 @ $8.60 · Grant/award (A): 2,240 @ $8.17 | EDGAR |
Recent 8-K events — AVITA Medical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K/A | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RCEL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →